Skip to main content
OpenTrials
Completed

NCT Number: NCT07027228

Virtual Reality Glasses and Music During Blood Donation on Anxiety, Vital Signs and Satisfaction of Donors

Blood is considered a limited resource in health centers and blood and blood products must be kept ready. The COVID-19 pandemic has caused a significant decrease in life-saving blood donations. In addition, negative experiences such as vasovagal reactions, painful needle sticks, psychological triggers and injuries that develop during blood donation cause donors to experience anxiety, negatively affecting their vital signs and the next donation experience. Therefore, donors should be supported by distraction techniques during blood donation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Satisfaction Anxiety Disorders Behavior Mental Disorders Personal Satisfaction

Age range

18 year–60 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Necmettin Erbakan University

Konya, 42090, Turkey (Türkiye)

About this study

Among the techniques used to divert attention, virtual reality glasses and music applications are frequently used. It is reported that virtual reality glasses are effective in reducing anxiety and supporting vital signs and satisfaction positively because they make you feel like you are somewhere else and music has positive effects on the human soul. This study aims to determine the effect of using virtual reality glasses and music during blood donation on donors' anxiety, vital signs and satisfaction.

A single-blind randomized controlled clinical trial design with one control and two intervention groups will be used in the study. The universe of the study will consist of donors who applied to the Blood Center of Necmettin Erbakan University Faculty of Medicine Hospital between June and July 2025. The sample of the study will consist of 225 male donors who meet the inclusion criteria and agree to participate in the study. Donors will be randomly assigned to 75 Intervention-1 Group (virtual reality glasses), 75 Intervention-2 Group (music) and 75 control groups using the simple randomization method. Data will be collected through face-to-face interviews with donors using the "Descriptive Characteristics Form", "State and Trait Anxiety Scale", "Vital Findings Follow-up Form" and "Satisfaction Scale". The first researcher will act as the evaluator and the second researcher will act as the implementer in the collection of data. Thus, differences between the evaluator and the implementer will be eliminated. Donors will be shown images of nature using virtual reality glasses, donors in the other group will listen to calming music, and the control group will not receive any intervention within the scope of standard practice. The data obtained from the study will be analyzed using the SPSS 22 package program and the data will be evaluated at a 95% confidence interval and a significance level of 0.05.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The criteria for inclusion in the study are as follows:

  • Being between the ages of 18-60,
  • Having a visual, hearing or perception disorder that prevents communication,
  • Having neurological, psychiatric or psychological diseases,
  • Donating whole blood.

Exclusion criteria

The exclusion criteria for the study are as follows:

  • Having vasovagal reactions,
  • Having complaints such as migraine, vertigo, active nausea, vomiting, headache,
  • Not having the blood donation chair in the semi-fowler position throughout the application,
  • Wanting to leave the study.

Treatment and study plan

Using virtual reality glasses or listening to music

Other

Donors in the intervention group will be randomly assigned and shown relaxing nature images through virtual reality glasses.

Using listening to music

Other

Donors in the intervention group will be randomly assigned and will listen to relaxing music.

Primary outcomes

  1. State and Trait Anxiety Scale

    Time frame: Up to two months

    The State and Trait Anxiety Scale is one of the scales frequently used in measuring anxiety. The scale consists of two parts: a 20-item "state anxiety form" and a 20-item "trait anxiety form". Individuals are asked to answer four-point Likert items (1: not at all, 2: a little, 3: a lot of the time, 4: completely) to determine what they are feeling at that moment. Since this study aims to measure donors' anxiety levels before and after blood donation, the state anxiety measuring part of the scale will be used. The scores obtained from the scale vary between 20 and 80. Although there is no anxiety threshold on the scale, a high score indicates a high anxiety level, and a low score indicates a low anxiety level.

  2. Blood pressure

    Time frame: Up to two months

    Individuals' blood pressure values will be determined with a sphygmomanometer.

  3. Pulse

    Time frame: Up to two months

    Individuals' pulse values will be determined by measuring with a pulse oximeter.

  4. Oxygen saturation

    Time frame: Up to two months

    Individuals' oxygen levels will be determined by measuring with a pulse oximeter.

  5. Respiratory

    Time frame: Up to two months

    The ventilation value of the individuals will be measured and recorded from the anterior thorax for one minute.

  6. Satisfaction Scale

    Time frame: Up to two months

    It is an evaluation form consisting of five statements (5: Very satisfied, 4: Satisfied, 3: Undecided, 2: Not satisfied, 1: Not satisfied at all) to determine donors' satisfaction with the virtual reality glasses and music application. An increase in the score indicates an increase in satisfaction.

Sponsors and collaborators

Lead sponsor

Necmettin Erbakan University

Other

Registry information

Official study title

Effect of Using Virtual Reality Glasses and Music During Blood Donation on Anxiety, Vital Signs and Satisfaction of Donors: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 18, 2025
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.